Javara - Privia Medical Group North Texas - Frisco ( Site 0086) — Frisco, Texas

Javara - Privia Medical Group North Texas - Frisco ( Site 0086) is a clinical research site located in Frisco, Texas, United States 75035.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Javara - Privia Medical Group North Texas - Frisco ( Site 0086) has participated in 1 clinical trials.

Therapeutic areas: Respiratory Syncytial Virus Infection.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Frisco

Browse all research sites in Texas · View every site in Frisco

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Javara - Privia Medical Group North Texas - Frisco ( Site 0086)?

Javara - Privia Medical Group North Texas - Frisco ( Site 0086) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Javara - Privia Medical Group North Texas - Frisco ( Site 0086) conducted?

Javara - Privia Medical Group North Texas - Frisco ( Site 0086) has 1 clinical trials on record. Their work covers Respiratory Syncytial Virus Infection.

Is Javara - Privia Medical Group North Texas - Frisco ( Site 0086) accredited by Crixeo Clinical Trials?

Javara - Privia Medical Group North Texas - Frisco ( Site 0086) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Javara - Privia Medical Group North Texas - Frisco ( Site 0086)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.